In the present study we have investigated the effect of changes in the concentration of cytosolic free Ca2+ ([Ca2+] Ca2+ on its acylation was investigated by using platelet homogenates. These experiments showed that the acylation of lyso-PAF was inhibited by the exogenously added Ca2 , with a maximum effect at 1 mm. When the formation of endogenous lyso-PAF from the labelled pool of alkylacyl-GPC was examined, a prolonged increase in the concentration of lyso-PAF with a parallel and equally prolonged decrease in the cellular level of alkylacyl-GPC were observed after the addition of ionophore to intact platelets. The addition of EGTA reversed the effect of ionophore, thus permitting reacylation of lyso-PAF. In contrast, only a transient change in the level of lyso-PAF and alkylacyl-GPC was evoked by the addition of thrombin. Therefore we conclude that the inhibitory effect of Ca2+ on the deacetylation-reacylation of PAF-acether may have an important role in the regulation of its biosynthesis.
INTRODUCTION
PAF-acether (platelet-activating factor, l-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine, alkylacetyl-GPC), also known as 'PAF' is a phospholipid mediator of anaphylaxis and inflammation. It induces various cellular responses, including chemotactic reaction, aggregation and degranulation of platelets and neutrophils. PAF-acether, which is produced by numerous types of cells, is formed by the combined activities of a phospholipase A2 (PLA2) and an acetyltransferase [reviewed by Vargaftig et al. (1981) , Benveniste & Pretolani (1985) and Snyder (1985) ]. The conversion (inactivation) of PAF-acether by platelets is catalysed by a sequential deacetylation-reacylation, leading to the formation of alkylacyl-GPC (Alam et al., 1983; Pieroni & Hanahan, 1983; Touqui et al., 1983 Touqui et al., , 1985a . The deacetylation step, generating lyso-PAF, is a Ca2+-independent event catalysed by a cytosolic acetylhydrolase (Blank et al., 1981; Kramer et al., 1984; Touqui et al., 1985b) . In alveolar macrophages, lyso-PAF can be reacylated to alkylacyl-GPC by the combined activities of an acyl-CoA acyltransferase, a CoA-dependent and a CoA-independent transacylase . The transacylase-dependent reaction has been shown to be responsible for the transfer of arachidonic acid (AA) from phosphatidylcholine (PC) to lyso-PAF (Kramer et al., 1984; Malone et al., 1985) and is described as the main pathway for the reacylation of lyso-PAF in platelets. It is well documented that the biosynthesis of PAF-acether is a Ca2+-dependent event Ninio et al., 1982; Gomez-Cambronero et al., 1984 , 1985 ; however, the role of Ca2+ in the inactivation of PAF-acether has not been clearly defined. Previous reports are contradictory; for example, in some studies using intact platelets extracellular Ca2+ ([Ca2+] O) deprivation had no effect on PAF-acether catabolism (Alam et al., 1983; Pieroni & Hanahan, 1983; Touqui et al., 1983 Touqui et al., , 1985a , whereas studies using platelet membranes have shown that acylation of lyso-PAF is inhibited by Abbreviations used: PAF-acether, platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine, alkylacetyl-GPC); alkylacyl-GPC, 1-0-alkyl-2-acyl-sn-glycero-3-phosphocholine; lyso-PAF, lyso-(platelet-activating factor) (alkyl-lysoglycerophosphocholine); PC, phosphatidyl- (McKean & Silver, 1985) . The discrepancy between these results probably arises from the fact that, in the former studies, the cells were unstimulated: that is, in the absence of stimulation, changes in the concentration of exogenous Ca2+ would not significantly alter the Ca2+ concentration in the cytosol, where the acetylhydrolase enzyme is located. Both biosynthesis (Ludwig et al., 1985) and catabolism (Pieroni & Hanahan, 1983) of PAF-acether have been shown to be dependent on the concentration ofalbumin in the extracellular medium. As PAF-acether binds avidly to this protein, it is likely that albumin, by acting as a sink for PAF-acether, effectively reduces the amount of free PAF-acether available for re-uptake, and hence catabolism, by the platelets. Indeed, we have observed that the catabolism of PAF-acether by rabbit platelets was 3-5 times more rapid when the albumin content of the suspension buffer was replaced by gelatin (L. Touqui & B. B. Vargaftig, unpublished work) . Thus, during the present study, to assess the effect of Ca2+ on PAF-acether catabolism, we chose to replace albumin with gelatin in the suspension medium in order to maximize any effect of Ca2+ on PAF-acether catabolism. Saclay, France) . Synthetic standards (1-0-hexadecyl-2-stearoyl-sn-glycero-3-phosphocholine, PAF-acether and lyso-PAF) were prepared in the laboratory of Dr. J. J. Godfroid (Universite Paris VII, Paris, France). 1-0-[3H]Alkyl-2-acyl-sn-glycero-3-phosphocholine was prepared from platelets as described previously (Touqui et al., 1985a) . Plastic silica-gel plates for t.l.c., and all solvents, were from Merck.
MATERIALS AND METHODS

Materials
Methods
Studies with intact platelets. Conversion of PAFacether into alkylacyl-GPC. Whole blood was collected from the central ear artery of adult New Zealand rabbits into a saline (0.9% NaCl) solution containing 5 mM-EDTA. Formation of platelet-rich plasma and platelet washing procedures have been detailed before (Ardlie et al., 1970) . The final platelet suspension, in Tyrode's buffer, pH 7.4, containing MgCl2 (1 mM), CaCl2 (2 mM) and gelatin (2.5 mg/ml) (TG buffer), contained 5 x 108 cells/ml. Aliquots (1 ml) of washed platelets were incubated with 0.05 ,uCi of [3H]alkyl-PAF (80 Ci/mmol) at 37°C in the presence and absence of the ionophore A23187 or thrombin under the conditions described in the legend to Fig. I (below) . After the appropriate incubation times the reactions were terminated by transferring the entire platelet suspension to glass tubes containing 3 ml ofmethanol/chloroform (2: 1, v/v) at 4 'C. Thereafter the lipids were extracted by the method of Bligh & Dyer (1959) , separated by t.l.c. in the presence of authentic standards, and analysed as described previously (Touqui et al., 1985a Blank et al. (1981) ; briefly: 0.5 ml aliquots of washed platelets were incubated with 0.05 ,uCi of [3H]acetyl-PAF (9.8 Ci/mmol), under the conditions detailed in the Figure legends. After predetermined incubation times the reactions were terminated by the addition of 1 ml of chloroform/methanol (1:1, v/v). Phase partition was promoted by centrifugation (2 min at 10000 g), and samples from the aqueous phase containing [3H]acetate were carefully aspirated and their radioactive content measured by liquid-scintillation counting. The efficiency of acetate recovery into the aqueous phase, assessed by using radioactively labelled sodium acetate as an internal standard, was greater than 98%. The recovery of lipids (PAF-acether, alkylacyl-GPC and lyso-PAF) from the organic phase was also assessed by using radioactive standards and was calculated to be greater than 95%.
Studies with endogenous lyso-PAF. In other experiments the endogenous pool ofalkylacyl-GPC, the precursor oflyso-PAF, was labelled by the procedures described above. Briefly, platelets (10 ml) were incubated for 2 h with [3H]alkyl-PAF (0.1 FCi/ml final sp. radioactivity), washed twice with Ca2+-free Tyrode's buffer containing 0.25% BSA and resuspended in TG buffer. Aliquots (1 ml) were then stimulated with thrombin (1 unit/ml) or ionophore (1 SM) (see the legend to Fig. 5 ). The reactions were terminated at the appropriate times and lipids analysed by t.l.c. as described above.
Studies with platelet homogenates. Platelets, prepared as indicated above, were resuspended in Ca2+-free TG buffer (5 x 108 cells/ml) and homogenized as described by Barber & Jamieson (1970) . The total homogenate was then resuspended in the same volume of Ca2+-free TG buffer. Aliquots of total homogenates (0.5 ml, containing 50-100 ,ug of protein) were incubated with lyso-[3H]PAF (0.05 1sCi) in the presence of various concentrations of Ca2+ in the medium as shown in Fig. 4 (below). The reactions were then terminated and the lipids extracts analysed as described above.
Measurement of cytosolic free Ca2+ concentration ([Ca2+1j) . [Ca2+], was measured by using the Ca2+ indicator dye Quin2 as described by Tsien et al. (1982) .
Washed platelets were incubated with 15 ftM-Quin2 acetoxymethyl ester (Quin2-AM) (37°C). After 30 min, loaded platelets were centrifuged in the presence of EDTA (5 mM) (to remove extraneous Quin2-AM) and resuspended in TG buffer (containing [Ca2+]0 = 1 mM). (1 /tM) in the presence (-) or absence (0) of 5 mM-EGTA.
Control platelets were treated with the ionophore vehicle, 0.2% dimethyl sulphoxide (0). At the times indicated, the reactions were terminated and lipids analysed by t.l.c. as described in the Materials and methods section. The Figure shows the variation in radioactivity associated with alkylacyl-GPC ( ) and PAF-acether (----) as a percentage of the total radioactivity extracted (29074+2661 c.p.m./ml) and represents the results from two separate experiments performed in duplicate. The lyso-PAF content (8-10%), which remained constant over the time course examined, has been omitted from the Figure for clarity. The variation between experiments was + 10%. added) within 30 min. The addition of ionophore A23 187 to the platelet suspension (in the presence of [Ca2+]0 at 1 mM) immediately preceding the addition of labelled PAF-acether abolished completely the conversion of PAF-acether into alkylacyl-GPC over the time period (0-30 min) examined (Fig. 1 ). During this period the level of lyso-PAF, which contained 8-10% of the total platelet radioactivity, remained unchanged. The inhibitory effect of the ionopliore was not mediated by the release of ADP or by the formation of cyclo-oxygenase metabolites of AA, since pretreatment of the platelets with CP/CPK and/or aspirin did not prevent the ionophore-induced inhibition of alkylacyl-GPC formation (results not shown). However, chelation of extracellular Ca2+ by the addition of EGTA (5 mM) prevented the inhibitory effect of the ionophore and, in fact, resulted in a slight increase in the conversion of PAF-acether into alkylacyl-GPC (Fig. 1) .
In contrast with the prolonged inhibition produced by the ionophore, the addition of thrombin (1 unit/ml) only increased the lag time of alkylacyl-GPC formation. Indeed, in the presence of thrombin the radioactivity associated with alkylacyl-GPC represented 53 + 5% and 96 + 3.5 o (expressed as a percentage of the correspondVol. 241 ing control values; mean+ S.D. from three experiments) after 10 and 30 min incubation respectively.
As no accumulation of lyso-PAF was observed during the ionophore-induced inhibition of alkylacyl-GPC formation, it would seem likely that deacetylation of PAF-acether was affected. To determine whether this was indeed the case platelets were incubated with [3H]acetyl-PAF and the subsequent deacetylation monitored by measuring the release of [3H]acetate.
Addition of ionophore resulted in a prolonged inhibition of the acetate release (Fig. 2) . Here again, the effect of thrombin differs from that of the ionophore in that it only caused an increase in the lag time and displaced the time course of acetate release (the latter reached the control values after 30 min; Fig. 2) . Moreover, the inhibition of PAF-acether deacetylation by the ionophore could be reversed by chelating extracellular Ca2+ with EGTA, indicating that Ca2+ may directly inhibit acetylhydrolase (Fig. 3) . [Ca2+], is probably underestimated by this method, since recent studies using aequorin, the Ca2+-sensitive photoprotein, showed that [Ca2+]i reached 10-fold higher concentrations during platelet stimulation (Johnson et-al., 1985) .
In the presence of EGTA (i.e.
[Ca2+]0 = 0), the elevation of [Ca2+] , induced by the ionophore or thrombin was markedly decreased (results not shown).
As shown in Fig. 3 , thrombin-and ionophore-induced inhibition of acetate release exhibited a close correlation with the ability of these agents to elevate [Ca2+]1. On the other hand we examined the possibility that PKC, which is activated by various agonists such as thrombin (Nishizuka, 1984) , may influence the catabolism of PAF-acether. To assess this possibility we incubated platelets with PMA (a potent activator of PKC) at concentration of 50 ng/ml, which maximally activates PKC. Under these conditions we observed that the release of acetate was not affected by the addition of PMA over the period (0-30 min) examined, indicating that PKC activation is not involved in the control of acetylhydrolase activity (results not shown).
The conversion of PAF-acether into alkylacyl-GPC is catalysed by the sequential intervention of acetylhydrolase and transacylase, i.e. lyso-PAF is the obligatory intermediate (Touqui et al., 1985a; . Although the inhibition of acetylhydrolase (first step) would be sufficient to account for the Ca2+-induced inhibition of alkylacyl-GPC formation, this does not Incubations were conducted in the absence of other cofactors (ATP, CoA, Mg2+). These experimental conditions correspond to those described (Kramer et al., 1984; Malone et al., 1985) for optimal CoA-independent transacylase activity, which appears to be the principal pathway for the acylation of lyso-PAF in platelets. Under these conditions, Ca2+ evoked a concentrationdependent inhibition of alkylacyl-GPC formation and a parallel accumulation of lyso-PAF (Fig. 4) . Additional characterization of this enzyme established that it has a pH optimum of 7.5-8.0, was sensitive to N-ethylmaleimide (IC50 = 0.1 mM) and was unaffected by the addition of CoA, which is in agreement with the characteristics of the CoA-independent transacylase described by Kramer et al. (1984) .
The deacylation of alkylacyl-GPC by PLA2 activity is Ca2+-dependent (Albert & Snyder, 1983; Touqui et al., 1985a) , thus it could be argued that the apparent inhibition of alkylacyl-GPC formation may be due to Ca2+-induced PLA2 activation rather than Ca2+-induced transacylase inhibition (i.e. increased catabolism rather than decreased anabolism of alkylacyl-GPC). When the deacylation of alkylacyl-GPC was examined, by incubating purified [3H]alkylacyl-GPC with platelet homogenates in the presence of 1 mM-Ca2 , only 25. ation-reacylation, is unaffected by changes in the concentration of extracellular Ca2+ (Pieroni & Hanahan, 1983; Touqui et al., 1985a) . It has therefore been concluded that the inactivation of PAF-acether was a Ca2+-independent event; this conclusion must be Ca2+-induced inhibition of alkylacyl-GPC formation (results not shown). In addition we have also examined the effect of the ionophore and thrombin on the duration of endogenous lyso-PAF production. The cellular pool of alkylacyl-GPC, the precursor of lyso-PAF, was labelled as described previously (Touqui et al., 1985a) , and platelets washed and resuspended in TG buffer. Stimulation of platelets with thrombin produced a transient increase in the concentration of lyso-PAF and, in parallel over the same time course, a transient decrease in the level of alkylacyl-GPC was observed. In contrast, addition of ionophore A23 187 produced a prolonged elevation in the concentration of lyso-PAF and an equally prolonged decrease in the level of alkylacyl-GPC, both of which could be reversed by the addition of EGTA (Fig. 5) . This suggests that, during platelet stimulation, an increase in the level of [Ca2+] , impairs the acylation of endogenous lyso-PAF, leading to its accumulation within the cell, and confirm the results obtained in the experiments with exogenous lyso-PAF (Fig. 4) . before PAF-acether catabolism commenced. When the effect of Ca2+ on PAF-acether catabolism was examined in more detail, we established that both deacetylation of PAF-acether and reacylation of lyso-PAF (at least by a CoA-independent transacylase) were inhibited by Ca2+ both in vivo and in vitro. The physiological relevance of these observations is supported by the effectiveness of extracellular Ca2+ in blocking the reacylation of endogenous lyso-PAF produced during A23187-induced platelet activation. Our findings confirm the recent observations of McKean & Silver (1985) in human platelets and support the data reported by Kroner et al. (1981) that the incorporation of AA into PC, in bone-marrow-derived macrophages, displayed a marked inhibition in the presence of the Ca2+ ionophore A23187. We have previously observed that, in human platelets, thrombin caused a transient formation of PAF-acether the duration of which has been prolonged by a prior incubation of platelets with phenylmethanesulphonyl fluoride, a potent inhibitor of acetylhydrolase (Touqui et al., 1985b) . In contrast, no decline was observed in the A23187-induced formation of PAF-acether by rabbit platelets up to 40 min stimulation . These findings are in accordance with the results of the present study, i.e. failure of thrombin, in contrast with A23187, to block the catabolism of PAF-acether by rabbit platelets. The biosynthesis of PAF-acether, by activation of PLA2, is known to be a Ca2+-dependent event. The results of the present study indicate that Ca2+ potently inhibits both the deacetylation of PAF-acether and the reacylation of lyso-PAF. An agonist-induced elevation in [Ca2+] , is considered to be an important second messenger in platelet reactivity, regulating the various biochemical processes that mediate the cellular response. The physiological relevance of such an event (i.e. elevation of [Ca2+]1) on PAF-acether metabolism, therefore, would be to promote the accumulation of this endogenous mediator by stimulating its formation and inhibiting its degradation (Scheme 1). In addition, as AA is the major fatty acid incorporated into lyso-PAF, then inhibition of the reacylation reaction would also be expected to enhance the accumulation of free AA and thus pro-aggregatory icosanoids.
Scheme 1 summarizes the results of the present study and hypothesizes a proposal for the Ca2+-mediated regulation of PAF-acether catabolism within platelets.
